HUMAN MONOCLONAL-ANTIBODY THAT RECOGNIZES THE V3-REGION OF HUMAN IMMUNODEFICIENCY VIRUS-GP120 AND NEUTRALIZES THE HUMAN T-LYMPHOTROPIC VIRUS TYPE-IIIMN STRAIN

被引:114
作者
SCOTT, CF
SILVER, S
PROFY, AT
PUTNEY, SD
LANGLOIS, A
WEINHOLD, K
ROBINSON, JE
机构
[1] LOUISIANA STATE UNIV,MED CTR,DEPT PEDIAT,1542 TULANE AVE,NEW ORLEANS,LA 70112
[2] REPLIGEN CORP,CAMBRIDGE,MA 02139
[3] DUKE UNIV,SCH MED,DEPT SURG ONCOL,DURHAM,NC 27710
关键词
AIDS; epitope mapping; human immunodeficiency virus type 1; virus neutralization;
D O I
10.1073/pnas.87.21.8597
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We describe a human IgG1 monoclonal antibody (N701.9b) derived by Epstein-Barr virus transformation of B cells from a human immunodeficiency virus-seropositive asymptomatic donor. This antibody was shown to recognize the principal neutralizing domain contained within the V3 region of gp120 of the MN strain of human immunodeficiency virus and MN-like strains, as determined by binding to the PB-1 fragment of MN gp120 and to synthetic peptides corresponding to the V3 region of MN and related virus strains. The epitope identified by monoclonal antibody N701.9b was mapped to a segment of V3 containing at least 7 amino acids (amino acids 316-322), which is located in the 'tip' and 'right' side of the V3 loop of the MN strain. Furthermore, this antibody manifested potent type-specific fusion-inhibitory activity against the MN strain but not against the IIIB or RF virus strains. This antibody also neutralized four virus isolates that had MN-like V3 region sequences and failed to neutralize three other strains containing unrelated V3 region sequences. Our findings confirm that the V3 region stimulates type-specific neutralizing antibody during natural human immunodeficiency virus infection in humans. The potential clinical use of this antibody is discussed.
引用
收藏
页码:8597 / 8601
页数:5
相关论文
共 45 条
[1]  
ARTHUR LO, 1989, J VIROL, V63, P5048
[2]  
BANAPOUR B, 1987, J IMMUNOL, V139, P4027
[3]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 CHALLENGE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT ENVELOPE GLYCOPROTEIN GP120 [J].
BERMAN, PW ;
GROOPMAN, JE ;
GREGORY, T ;
CLAPHAM, PR ;
WEISS, RA ;
FERRIANI, R ;
RIDDLE, L ;
SHIMASAKI, C ;
LUCAS, C ;
LASKY, LA ;
EICHBERG, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5200-5204
[4]   PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].
BERMAN, PW ;
GREGORY, TJ ;
RIDDLE, L ;
NAKAMURA, GR ;
CHAMPE, MA ;
PORTER, JP ;
WURM, FM ;
HERSHBERG, RD ;
COBB, EK ;
EICHBERG, JW .
NATURE, 1990, 345 (6276) :622-625
[5]   VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES [J].
CHAKRABARTI, S ;
BRECHLING, K ;
MOSS, B .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3403-3409
[6]   EXPRESSION OF THE HTLV-III ENVELOPE GENE BY A RECOMBINANT VACCINIA VIRUS [J].
CHAKRABARTI, S ;
ROBERTGUROFF, M ;
WONGSTAAL, F ;
GALLO, RC ;
MOSS, B .
NATURE, 1986, 320 (6062) :535-537
[7]  
EMINI EA, 1990, IN PRESS J VIROL
[8]   AN ENGINEERED POLIOVIRUS CHIMERA ELICITS BROADLY REACTIVE HIV-1 NEUTRALIZING ANTIBODIES [J].
EVANS, DJ ;
MCKEATING, J ;
MEREDITH, JM ;
BURKE, KL ;
KATRAK, K ;
JOHN, A ;
FERGUSON, M ;
MINOR, PD ;
WEISS, RA ;
ALMOND, JW .
NATURE, 1989, 339 (6223) :385-388
[9]   DEVELOPMENT AND EVALUATION OF A VACCINE FOR HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION [J].
FAUCI, AS ;
GALLO, RC ;
KOENIG, S ;
SALK, J ;
PURCELL, RH .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (05) :373-385
[10]   THE ACQUIRED IMMUNODEFICIENCY SYNDROME - AN UPDATE [J].
FAUCI, AS ;
MASUR, H ;
GELMANN, EP ;
MARKHAM, PD ;
HAHN, BH ;
LANE, HC .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (06) :800-813